JCR Pharmaceuticals
Japan - HyogoPharmaceutical
Focus: JCR Pharmaceuticals is a Japan-based specialist in recombinant DNA technology and blood-brain barrier (BBB)-crossing antibodies, focused on rare neurological and lysosomal storage disorders. The company operates as a mid-cap biotech with a concentrated pipeline in orphan indications.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About JCR Pharmaceuticals
AI assessmentNot HiringNo open roles listed right now. Follow JCR Pharmaceuticals to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthStrong
Pipeline
Late-stage
4 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Phase 1/2
Clinical Trials (1)
NCT06488924An Open-label Phase I/II Study of JR-446 in Mucopolysaccharidosis Type IIIB
Phase 1/2Help build intelligence for JCR Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.